EnerSpar and Israeli-Based Nurexone Announce Definitive Agreement
- Written by Newsfile
Calgary, Alberta--(Newsfile Corp. - January 18, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") is pleased to announce that they have entered into an arm's length securities exchange agreement dated January 3, 2022 (the "Agreement"), with Nurexone Biologic Ltd. ("Nurexone") and the shareholders of Nurexone...